Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


03.04.2017

5 BMJ
2 Clin Infect Dis
1 J Infect Dis
3 Lancet
1 Lancet Infect Dis
4 Lancet Respir Med
5 PLoS One
1 Proc Natl Acad Sci U S A
1 Respir Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. CHAVAN D
    Fighting TB requires empowered patients.
    BMJ. 2017;356:i6344.
    PubMed     Text format    

  2. KANDASAMY R, Voysey M, McQuaid F, de Nie K, et al
    Non-specific immunological effects of selected routine childhood immunisations: systematic review.
    BMJ. 2016;355:i5225.
    PubMed     Text format     Abstract available

  3. HIGGINS JP, Soares-Weiser K, Lopez-Lopez JA, Kakourou A, et al
    Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.
    BMJ. 2016;355:i5170.
    PubMed     Text format     Abstract available

  4. COUSINS S
    Funding shortfalls put target to end TB epidemic by 2035 at risk.
    BMJ. 2016;355:i5779.
    PubMed     Text format    

  5. TORJESEN I
    Joe Smith.
    BMJ. 2017;356:j397.
    PubMed     Text format    


    Clin Infect Dis

  6. BROGER T, Basu Roy R, Filomena A, Greef CH, et al
    Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents.
    Clin Infect Dis. 2017;64:947-955.
    PubMed     Text format     Abstract available

  7. RAOULT D
    Old Antibiotics for Tuberculosis.
    Clin Infect Dis. 2017;64:983.
    PubMed     Text format    


    J Infect Dis

  8. JANSSEN S, Schutz C, Ward AM, Huson MA, et al
    Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study.
    J Infect Dis. 2017;215:247-258.
    PubMed     Text format     Abstract available


    Lancet

  9. SHARMA DC
    New plan to end tuberculosis in south and southeast Asia.
    Lancet. 2017;389:1183.
    PubMed     Text format    

  10. ADAM BU, Cosford P, Anderson SR, Abubakar I, et al
    Sustaining tuberculosis decline in the UK.
    Lancet. 2017;389:1176-1177.
    PubMed     Text format    

  11. PAI M, Correa N, Mistry N, Jha P, et al
    Reducing global tuberculosis deaths-time for India to step up.
    Lancet. 2017;389:1174-1176.
    PubMed     Text format    


    Lancet Infect Dis

  12. OTERO L, Villegas L, Huaman M, Sterling T, et al
    The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment.
    Lancet Infect Dis. 2017;17:363-364.
    PubMed     Text format    


    Lancet Respir Med

  13. DOWDY DW, Theron G, Tornheim JA, Kendall EA, et al
    Drug-resistant tuberculosis in 2017: at a crossroads.
    Lancet Respir Med. 2017 Mar 15. pii: S2213-2600(17)30081.
    PubMed     Text format    

  14. GRAINGER E, Hellier R, Stanley D, Feetham L, et al
    The war on tuberculosis must continue.
    Lancet Respir Med. 2017 Mar 15. pii: S2213-2600(17)30082.
    PubMed     Text format    

  15. TANDAY S
    Will we ever eliminate tuberculosis, the voiceless disease?
    Lancet Respir Med. 2017 Mar 15. pii: S2213-2600(17)30080.
    PubMed     Text format    

  16. DHEDA K, Gumbo T, Maartens G, Dooley KE, et al
    The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.
    Lancet Respir Med. 2017 Mar 15. pii: S2213-2600(17)30079.
    PubMed     Text format     Abstract available


    PLoS One

  17. HAVUMAKI J, Hillemann D, Ismail N, Omar SV, et al
    Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study.
    PLoS One. 2017;12:e0173804.
    PubMed     Text format     Abstract available

  18. KIM C, Park SH, Oh SY, Kim SS, et al
    Comparison of chest CT findings in nontuberculous mycobacterial diseases vs. Mycobacterium tuberculosis lung disease in HIV-negative patients with cavities.
    PLoS One. 2017;12:e0174240.
    PubMed     Text format     Abstract available

  19. HONG EP, Go MJ, Kim HL, Park JW, et al
    Risk prediction of pulmonary tuberculosis using genetic and conventional risk factors in adult Korean population.
    PLoS One. 2017;12:e0174642.
    PubMed     Text format     Abstract available

  20. CUI Z, Lin M, Nie S, Lan R, et al
    Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China.
    PLoS One. 2017;12:e0173976.
    PubMed     Text format     Abstract available

  21. ADANE K, Spigt M, Johanna L, Noortje D, et al
    Tuberculosis knowledge, attitudes, and practices among northern Ethiopian prisoners: Implications for TB control efforts.
    PLoS One. 2017;12:e0174692.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  22. LIU C, Zhao Z, Fan J, Lyon CJ, et al
    Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring.
    Proc Natl Acad Sci U S A. 2017 Mar 27. pii: 201621360.
    PubMed     Text format     Abstract available


    Respir Med

  23. JO KW, Yeo Y, Sung H, Kim MN, et al
    Corrigendum to "Analysis of discrepant results between the Genotype(R) MTBDRplus assay and an antimicrobial-susceptibility test for isoniazid-resistant tuberculosis'"[Respiratory Med. 122 (January 2017) 12-17].
    Respir Med. 2017;125:24.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: